InformAI is a Houston, Texas healthcare technology company building AI software for clinicians. RadOncAI is radiation therapy dose-planning software that generates an optimised radiation plan targeting tumours while minimising exposure of adjacent healthy tissue, with a focus on head and neck cancers; the site announces FDA 510(k) clearance for it as software as a medical device (K253050). TransplantAI is a donor-recipient informatics platform for transplant decisions, and SinusAI is a CT imaging diagnostics tool that the site describes as in development.
Regulatory status differs by product and matters here: only RadOncAI is described as cleared, while TransplantAI is supported by peer-reviewed research, including a 2026 Annals of Surgery Open paper reporting that an XGBoost model outperformed traditional regression-based transplant regulatory models, and SinusAI is not yet a released product. The company mentions continuing NIH grants and says it partners with medical institutions and channel partners, without naming them on the page.
This is enterprise clinical software, so there is no published pricing or self-serve access. Ask for the cleared indications for use, the validation populations, and how outputs are reviewed by a clinician, since a treatment-plan generator is only as safe as the review step around it.
